Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Day 37 since filing EOP2 meeting request. AP is past the halfway mark of a maximum 70 day window to meet with the FDA. There is no urgency. Hence, the news/data trickling out about IL-6 in the Ph2b COVID-19 study (it'll never end...x rays) was given a big spin of the wheel by the gameshow CEO to suggest it's time to look beyond the COVID-19 study. Yeah, the CEO is highlighting the need to refocus the story on the IPF/CC study with no true end in sight. I could be wrong but thus far I've been waaay more right about the "leadership" at the helm. They're natural born losers who know how to snatch defeat from the jaws of victory in pennyland.

M$